Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Clin Cardiol

Retrieve available abstracts of 99 articles:
HTML format

Single Articles

    November 2021
  1. SIMON J, El Mahdiui M, Smit JM, Szaraz L, et al
    Left atrial appendage size is a marker of atrial fibrillation recurrence after radiofrequency catheter ablation in patients with persistent atrial fibrillation.
    Clin Cardiol. 2021 Nov 19. doi: 10.1002/clc.23748.
    PubMed     Abstract available

  2. LEE S, Jeevaratnam K, Liu T, Chang D, et al
    Risk stratification of cardiac arrhythmias and sudden cardiac death in type 2 diabetes mellitus patients receiving insulin therapy: A population-based cohort study.
    Clin Cardiol. 2021;44:1602-1612.
    PubMed     Abstract available

    October 2021
  3. VONDERLIN N, Kortuem K, Siebermair J, Kohrmann M, et al
    Central retinal artery occlusion as a first sign of atrial fibrillation: A 3-year retrospective single-center analysis.
    Clin Cardiol. 2021 Oct 28. doi: 10.1002/clc.23673.
    PubMed     Abstract available

  4. STRAUBE F, Pongratz J, Hartl S, Brueck B, et al
    Cardiac computed tomography angiography-derived analysis of left atrial appendage morphology and left atrial dimensions for the prediction of atrial fibrillation recurrence after pulmonary vein isolation.
    Clin Cardiol. 2021 Oct 14. doi: 10.1002/clc.23743.
    PubMed     Abstract available

  5. POMMIER T, Guenancia C, Richard C, Sagnard A, et al
    Safety and efficacy of left atrial appendage occlusion with the ACP or Watchman device guided by intracardiac echocardiography from the left atrium.
    Clin Cardiol. 2021;44:1402-1408.
    PubMed     Abstract available

  6. GLIBBERY M, Banks L, Altaha MA, Bentley RF, et al
    Atrial structure and function in middle-aged, physically-active males and females: A cardiac magnetic resonance study.
    Clin Cardiol. 2021;44:1467-1474.
    PubMed     Abstract available

  7. HOSSEINI Z, Mollazadeh R, Dehghan-Manshadi SA, Mohebi M, et al
    Association between exposure to Efavirenz and substrates of dysrhythmia in HIV-infected young adults.
    Clin Cardiol. 2021;44:1448-1456.
    PubMed     Abstract available

    September 2021
  8. LI L, Selvin E, Hoogeveen RC, Soliman EZ, et al
    6-year change in high sensitivity cardiac troponin T and the risk of atrial fibrillation in the Atherosclerosis Risk in Communities cohort.
    Clin Cardiol. 2021 Sep 21. doi: 10.1002/clc.23727.
    PubMed     Abstract available

  9. SEEWOSTER T, Dinov B, Nedios S, Hindricks G, et al
    Biatrial volume ratio predicts low voltage areas in atrial fibrillation.
    Clin Cardiol. 2021 Sep 8. doi: 10.1002/clc.23720.
    PubMed     Abstract available

  10. HE G, Liu H, Huang X, Deng X, et al
    Intracardiac versus transesophageal echocardiography for diagnosis of left atrial appendage thrombosis in atrial fibrillation: A meta-analysis.
    Clin Cardiol. 2021 Sep 3. doi: 10.1002/clc.23698.
    PubMed     Abstract available

  11. CHRISTOPH M, Youssef A, Svitil J, Forkmann M, et al
    Comparison of uninterrupted direct oral anticoagulation with vitamin-K antagonists during AF-ablation in the clinical routine. A single center register.
    Clin Cardiol. 2021;44:1243-1248.
    PubMed     Abstract available

    August 2021
  12. XIANG B, Ma W, Yan S, Chen J, et al
    Rhythm outcomes after aortic valve surgery: Treatment and evolution of new-onset atrial fibrillation.
    Clin Cardiol. 2021 Aug 14. doi: 10.1002/clc.23703.
    PubMed     Abstract available

  13. MIAO Y, Xu M, Zhang C, Liu H, et al
    An echocardiographic model for predicting the recurrence of paroxysmal atrial fibrillation after circumferential pulmonary vein ablation.
    Clin Cardiol. 2021 Aug 11. doi: 10.1002/clc.23712.
    PubMed     Abstract available

  14. ZELJKOVIC I, Brusich S, Scherr D, Velagic V, et al
    Differences in activated clotting time and total unfractionated heparin dose during pulmonary vein isolation in patients on different anticoagulation therapy.
    Clin Cardiol. 2021;44:1177-1182.
    PubMed     Abstract available

  15. D'SOUZA S, Elshazly MB, Dargham SR, Donnellan E, et al
    Atrial fibrillation catheter ablation complications in obese and diabetic patients: Insights from the US Nationwide Inpatient Sample 2005-2013.
    Clin Cardiol. 2021;44:1151-1160.
    PubMed     Abstract available

    July 2021
  16. BARKAS F, Bechlioulis A, Liberopoulos E
    Bradycardia and coronavirus disease 2019: What is behind?
    Clin Cardiol. 2021 Jul 30. doi: 10.1002/clc.23701.

  17. MAO YJ, Feng WY, Huang QY, Yu FL, et al
    Meta-analysis of cryoballoon ablation versus antiarrhythmic drugs as initial therapy for symptomatic atrial fibrillation.
    Clin Cardiol. 2021 Jul 29. doi: 10.1002/clc.23695.
    PubMed     Abstract available

  18. KUMAR S, Arcuri C, Chaudhuri S, Gupta R, et al
    Remdesivir therapy associated with Bradycardia in SARS-CoV2.
    Clin Cardiol. 2021 Jul 28. doi: 10.1002/clc.23700.

  19. WATANABE E, Noyama S, Kiyono K, Inoue H, et al
    Comparison among random forest, logistic regression, and existing clinical risk scores for predicting outcomes in patients with atrial fibrillation: A report from the J-RHYTHM registry.
    Clin Cardiol. 2021 Jul 28. doi: 10.1002/clc.23688.
    PubMed     Abstract available

  20. CUI YK, Dong JZ, Du X, Hu R, et al
    Comparison of prognosis and outcomes of catheter ablation versus drug therapy in patients with atrial fibrillation and stable coronary artery disease: A prospective propensity-score matched cohort study.
    Clin Cardiol. 2021 Jul 28. doi: 10.1002/clc.23699.
    PubMed     Abstract available

  21. JIANG H, Jiang Y, Ma H, Zeng H, et al
    Effects of rivaroxaban and warfarin on the risk of gastrointestinal bleeding and intracranial hemorrhage in patients with atrial fibrillation: Systematic review and meta-analysis.
    Clin Cardiol. 2021 Jul 24. doi: 10.1002/clc.23690.
    PubMed     Abstract available

  22. SUNAGA A, Masuda M, Inoue K, Tanaka N, et al
    The efficacy and safety of left atrial low-voltage area guided ablation for recurrence prevention compared to pulmonary vein isolation alone in patients with persistent atrial fibrillation trial: Design and rationale.
    Clin Cardiol. 2021 Jul 22. doi: 10.1002/clc.23677.
    PubMed     Abstract available

  23. KUMAR S, Arcuri C, Chaudhuri S, Gupta R, et al
    Response to Dr. Masaya Miyauchi and Dr. Teruhiko Imamura, Clinical implication of COVID-19 associated bradycardia.
    Clin Cardiol. 2021 Jul 9. doi: 10.1002/clc.23675.

    June 2021
  24. ZHU J, Tan X, Zhou JZ
    Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A systematic review and meta-analysis.
    Clin Cardiol. 2021 Jun 25. doi: 10.1002/clc.23678.
    PubMed     Abstract available

  25. SAWASAKI K, Inden Y, Hosoya N, Muto M, et al
    Defibrillation threshold of internal cardioversion prior to ablation predicts atrial fibrillation recurrence.
    Clin Cardiol. 2021 Jun 23. doi: 10.1002/clc.23679.
    PubMed     Abstract available

  26. MIYAUCHI M, Imamura T
    Clinical implication of COVID-19 associated bradycardia.
    Clin Cardiol. 2021 Jun 19. doi: 10.1002/clc.23674.

  27. DONG Z, Du X, Hou XX, He L, et al
    Effect of electrical cardioversion on 1-year outcomes in patients with early recurrence after catheter ablation for atrial fibrillation.
    Clin Cardiol. 2021 Jun 8. doi: 10.1002/clc.23663.
    PubMed     Abstract available

  28. WANG W, Chen Q, Zhang F, Chen X, et al
    Radiofrequency catheter ablation combined with spironolactone in the treatment of atrial fibrillation: A single-center randomized controlled study.
    Clin Cardiol. 2021 Jun 2. doi: 10.1002/clc.23659.
    PubMed     Abstract available

  29. HOU Q, Feng L, Yang J, Liu Y, et al
    The immediate trends in atrial electrical remodeling for paroxysmal atrial fibrillation across different modes of catheter ablation.
    Clin Cardiol. 2021 Jun 1. doi: 10.1002/clc.23617.
    PubMed     Abstract available

  30. LU WD, Chen JY
    The optimal cutoff of atrial high-rate episodes for neurological events in patients with dual chamber permanent pacemakers.
    Clin Cardiol. 2021;44:871-879.
    PubMed     Abstract available

  31. CHIANG LLW, Li C, Hong KL, Hui WS, et al
    The use of minimal fluoroscopy for cardiac electrophysiology procedures: A meta-analysis and review of the literature.
    Clin Cardiol. 2021;44:814-823.
    PubMed     Abstract available

  32. LIN J, Qian Y, Chen Q, Zhang M, et al
    The burden of premature ventricular contractions predicts adverse fetal and neonatal outcomes among pregnant women without structural heart disease: A prospective cohort study.
    Clin Cardiol. 2021;44:833-838.
    PubMed     Abstract available

  33. LI S, Deng Y, Tong Y, Xiong Q, et al
    Assessment of non-vitamin K antagonist oral anticoagulants for the management of left ventricular thrombus.
    Clin Cardiol. 2021;44:754-760.
    PubMed     Abstract available

    May 2021
  34. ECCLESTON DS, Kim JM, Ten Berg JM, Steg PG, et al
    The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic
    Clin Cardiol. 2021 May 27. doi: 10.1002/clc.23649.
    PubMed     Abstract available

  35. GUO Z, Ding X, Ye Z, Chen W, et al
    Non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients with previous stroke or intracranial hemorrhage: A systematic review and meta-analysis of observational studies.
    Clin Cardiol. 2021 May 20. doi: 10.1002/clc.23647.
    PubMed     Abstract available

  36. KUMAR S, Arcuri C, Chaudhuri S, Gupta R, et al
    A novel study on SARS-COV-2 virus associated bradycardia as a predictor of mortality-retrospective multicenter analysis.
    Clin Cardiol. 2021 May 8. doi: 10.1002/clc.23622.
    PubMed     Abstract available

    April 2021
  37. NIE C, Zhu C, Xiao M, Yang Q, et al
    Mid-ventricular obstruction is associated with non-sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy.
    Clin Cardiol. 2021;44:555-562.
    PubMed     Abstract available

  38. YAMAMOTO T, Iwasaki YK, Fujimoto Y, Oka E, et al
    The characteristics and efficacy of catheter ablation of focal atrial tachycardia arising from an epicardial site.
    Clin Cardiol. 2021;44:563-572.
    PubMed     Abstract available

    March 2021
  39. GRYMONPREZ M, Capiau A, De Backer TL, Steurbaut S, et al
    The impact of underweight and obesity on outcomes in anticoagulated patients with atrial fibrillation: A systematic review and meta-analysis on the obesity paradox.
    Clin Cardiol. 2021 Mar 26. doi: 10.1002/clc.23593.
    PubMed     Abstract available

  40. ONUKI T, Shoji M, Sugiyama H, Arai S, et al
    Clinical predictors for bradycardia and supraventricular tachycardia necessitating therapy in patients with unexplained syncope monitored by insertable cardiac monitor.
    Clin Cardiol. 2021 Mar 16. doi: 10.1002/clc.23594.
    PubMed     Abstract available

  41. GUDMUNDSDOTTIR KK, Fredriksson T, Svennberg E, Al-Khalili F, et al
    Performance of pulse palpation compared to one-lead ECG in atrial fibrillation screening.
    Clin Cardiol. 2021 Mar 16. doi: 10.1002/clc.23595.
    PubMed     Abstract available

  42. OUALI S, Ben Halima A, Chabrak S, Chettaoui R, et al
    Epidemiological characteristics, management, and outcomes of atrial fibrillation in TUNISIA: Results from the National Tunisian Registry of Atrial Fibrillation (NATURE-AF).
    Clin Cardiol. 2021 Mar 11. doi: 10.1002/clc.23558.
    PubMed     Abstract available

  43. ZHANG S, Guo J, Tao A, Zhang B, et al
    Clinical outcomes of left bundle branch pacing compared to right ventricular apical pacing in patients with atrioventricular block.
    Clin Cardiol. 2021 Mar 11. doi: 10.1002/clc.23513.
    PubMed     Abstract available

  44. LIU X, Huang M, Ye C, Xiao X, et al
    Effect of non-recommended doses versus recommended doses of direct oral anticoagulants in atrial fibrillation patients: A meta-analysis.
    Clin Cardiol. 2021 Mar 7. doi: 10.1002/clc.23586.
    PubMed     Abstract available

  45. PANCHOLY SB, Patel GA, Patel DD, Patel N, et al
    Association between insurance status and in-hospital outcomes in patients with out-of-hospital ventricular fibrillation arrest.
    Clin Cardiol. 2021 Mar 4. doi: 10.1002/clc.23564.
    PubMed     Abstract available

  46. NARLA VA
    Sudden cardiac death in HIV-infected patients: A contemporary review.
    Clin Cardiol. 2021;44:316-321.
    PubMed     Abstract available

    February 2021
  47. SANTALA OE, Lipponen JA, Jantti H, Rissanen TT, et al
    Necklace-embedded electrocardiogram for the detection and diagnosis of atrial fibrillation.
    Clin Cardiol. 2021 Feb 25. doi: 10.1002/clc.23580.
    PubMed     Abstract available

  48. PARK YJ, Yu HT, Kim TH, Uhm JS, et al
    Effectiveness and safety of single transseptal ablation for atrial fibrillation in real-word practice.
    Clin Cardiol. 2021 Feb 22. doi: 10.1002/clc.23574.
    PubMed     Abstract available

  49. CHOI JH, Kwon HJ, Kim HR, Park SJ, et al
    Earliest activation time is a good predictor of successful ablation of idiopathic outflow tract ventricular arrhythmias.
    Clin Cardiol. 2021 Feb 20. doi: 10.1002/clc.23578.
    PubMed     Abstract available

  50. YANG Z, Xu M, Zhang C, Liu H, et al
    A predictive model using left atrial function and B-type natriuretic peptide level in predicting the recurrence of early persistent atrial fibrillation after radiofrequency ablation.
    Clin Cardiol. 2021 Feb 8. doi: 10.1002/clc.23557.
    PubMed     Abstract available

  51. KUMAR N, Echouffo-Tcheugui JB
    Diabetes and atrial fibrillation in hospitalized patients in the United States.
    Clin Cardiol. 2021 Feb 4. doi: 10.1002/clc.23533.
    PubMed     Abstract available

  52. KRITTAYAPHONG R, Pumprueg S, Thongsri T, Wiwatworapan W, et al
    Impact of anemia on clinical outcomes of patients with atrial fibrillation: The COOL-AF registry.
    Clin Cardiol. 2021 Feb 4. doi: 10.1002/clc.23559.
    PubMed     Abstract available

    January 2021
  53. LI X, Shang W, Zhang N, Xie Y, et al
    Remote magnetic-guided ablation for three origins of idiopathic ventricular arrhythmias with right bundle branch block and superior axis.
    Clin Cardiol. 2021 Jan 20. doi: 10.1002/clc.23546.
    PubMed     Abstract available

  54. CHEN J, Yu P, Ma J, Zheng C, et al
    Does subclinical atrial fibrillation independently predict adverse outcomes in patients with heart failure and cardiac resynchronization therapy defibrillator.
    Clin Cardiol. 2021 Jan 19. doi: 10.1002/clc.23547.

  55. ABUDAN AA, Vaidya VR, Tripathi B, Noseworthy PA, et al
    Burden of arrhythmia in hospitalized HIV patients.
    Clin Cardiol. 2021;44:66-77.
    PubMed     Abstract available

  56. KOSIUK J, Fiedler L, Ernst S, Duncker D, et al
    Fluoroscopy usage in contemporary interventional electrophysiology: Insights from a European registry.
    Clin Cardiol. 2021;44:36-42.
    PubMed     Abstract available

    December 2020
  57. WANG Z, Jia L, Shi T, Liu C, et al
    General anesthesia is not superior to sedation in clinical outcome and cost-effectiveness for ablation of persistent atrial fibrillation.
    Clin Cardiol. 2020 Dec 29. doi: 10.1002/clc.23528.
    PubMed     Abstract available

  58. REN J, Yang Y, Zhu J, Wu S, et al
    Type of atrial fibrillation and outcomes in patients without oral anticoagulants.
    Clin Cardiol. 2020 Dec 12:e23519. doi: 10.1002/clc.23519.
    PubMed     Abstract available

  59. WANG J, Miao C, Yang G, Xu L, et al
    Lead I R-wave amplitude to distinguish ventricular arrhythmias with lead V3 transition originating from the left versus right ventricular outflow tract.
    Clin Cardiol. 2020 Dec 10. doi: 10.1002/clc.23511.
    PubMed     Abstract available

  60. NEDIOS S, Doering M, Darma A, Lucas J, et al
    Predictors of rhythm outcomes after cardiac resynchronization therapy in atrial fibrillation patients: When should we use an atrial lead?
    Clin Cardiol. 2020 Dec 9. doi: 10.1002/clc.23527.
    PubMed     Abstract available

    November 2020
  61. WANG X, Song B, Qiu C, Han Z, et al
    The effect of left atrial remodeling after cryoballoon ablation and radiofrequency ablation for paroxysmal atrial fibrillation.
    Clin Cardiol. 2020 Nov 18. doi: 10.1002/clc.23507.
    PubMed     Abstract available

  62. NEDIOS S, Lobe S, Knopp H, Seewoster T, et al
    Left atrial activation and asymmetric anatomical remodeling in patients with atrial fibrillation: The relation between anatomy and function.
    Clin Cardiol. 2020 Nov 17:e23515. doi: 10.1002/clc.23515.
    PubMed     Abstract available

  63. MAZZA A, Bendini MG, Leggio M, De Cristofaro R, et al
    Continuous monitoring of sleep-disordered breathing with pacemakers: Indexes for risk stratification of atrial fibrillation and risk of stroke.
    Clin Cardiol. 2020 Nov 12. doi: 10.1002/clc.23489.
    PubMed     Abstract available

  64. KAWAMURA Y, Yokoyama H, Kitayama K, Miura N, et al
    Clinical impact of complete atrioventricular block in patients with ST-segment elevation myocardial infarction.
    Clin Cardiol. 2020 Nov 12. doi: 10.1002/clc.23510.
    PubMed     Abstract available

  65. MEYRE PB, Springer A, Aeschbacher S, Blum S, et al
    Association of psychosocial factors with all-cause hospitalizations in patients with atrial fibrillation.
    Clin Cardiol. 2020 Nov 10. doi: 10.1002/clc.23503.
    PubMed     Abstract available

    October 2020
  66. CHEN CF, Wu J, Jin CL, Liu MJ, et al
    Comparison of high-power short-duration and low-power long-duration radiofrequency ablation for treating atrial fibrillation: Systematic review and meta-analysis.
    Clin Cardiol. 2020 Oct 27. doi: 10.1002/clc.23493.
    PubMed     Abstract available

  67. KORNEJ J, Henger S, Seewoster T, Teren A, et al
    Prevalence of atrial fibrillation dependent on coronary artery status: Insights from the LIFE-Heart Study.
    Clin Cardiol. 2020 Oct 27. doi: 10.1002/clc.23490.
    PubMed     Abstract available

  68. ZHAO Z, Yang Y, Wang J, Dong Z, et al
    Combined treatment with valsartan and fluvastatin to delay disease progression in nonpermanent atrial fibrillation with hypertension: A clinical trial.
    Clin Cardiol. 2020 Oct 26. doi: 10.1002/clc.23487.
    PubMed     Abstract available

  69. CHENG YJ, Zhao XX, Pan SP, Pan JM, et al
    Association of early repolarization pattern with cardiovascular outcomes in middle-aged population: A cohort study.
    Clin Cardiol. 2020 Oct 26. doi: 10.1002/clc.23488.
    PubMed     Abstract available

  70. BLOMSTROM-LUNDQVIST C, Marrouche N, Connolly S, Corp Dit Genti V, et al
    Efficacy and safety of dronedarone by atrial fibrillation history duration: Insights from the ATHENA study.
    Clin Cardiol. 2020 Oct 20. doi: 10.1002/clc.23463.
    PubMed     Abstract available

  71. WILLY K, Wasmer K, Dechering DG, Kobe J, et al
    Ablation of paroxysmal and persistent atrial fibrillation in the very elderly real-world data on safety and efficacy.
    Clin Cardiol. 2020 Oct 19. doi: 10.1002/clc.23485.
    PubMed     Abstract available

  72. HERMANS ANL, van der Velden RMJ, Gawalko M, Verhaert DVM, et al
    On-demand mobile health infrastructures to allow comprehensive remote atrial fibrillation and risk factor management through teleconsultation.
    Clin Cardiol. 2020 Oct 8. doi: 10.1002/clc.23469.
    PubMed     Abstract available

  73. WU JT, Zhao DQ, Li FF, Zhang LM, et al
    Effect of pulmonary vein isolation on atrial fibrillation recurrence after accessory pathway ablation in patients with Wolff-Parkinson-White syndrome.
    Clin Cardiol. 2020 Oct 1. doi: 10.1002/clc.23470.
    PubMed     Abstract available

    September 2020
  74. ARAI S, Kawamura M, Gokan T, Yoshikawa K, et al
    Relationship between device-detected subclinical atrial fibrillation and heart failure in patients with cardiac resynchronization therapy defibrillator.
    Clin Cardiol. 2020 Sep 29. doi: 10.1002/clc.23471.
    PubMed     Abstract available

  75. GUO J, Li L, Xiao G, Ye T, et al
    Remarkable response to cardiac resynchronization therapy via left bundle branch pacing in patients with true left bundle branch block.
    Clin Cardiol. 2020 Sep 22. doi: 10.1002/clc.23462.
    PubMed     Abstract available

  76. SHARMA S, Barot HV, Schwartzman AD, Ganatra S, et al
    Risk and predictors of dyssynchrony cardiomyopathy in left bundle branch block with preserved left ventricular ejection fraction.
    Clin Cardiol. 2020 Sep 17. doi: 10.1002/clc.23467.
    PubMed     Abstract available

  77. WEI Z, Bing Z, Shaohuan Q, Yanran W, et al
    Expression of miRNAs in plasma exosomes derived from patients with atrial fibrillation.
    Clin Cardiol. 2020 Sep 17. doi: 10.1002/clc.23461.
    PubMed     Abstract available

  78. ZHOU B, Zhao S, Tang M, Chen K, et al
    Overweight and obesity as protective factors against mortality in nonischemic cardiomyopathy patients with an implantable cardioverter defibrillator.
    Clin Cardiol. 2020 Sep 16. doi: 10.1002/clc.23458.
    PubMed     Abstract available

  79. CAMM AJ, Amarenco P, Haas S, Bach M, et al
    Impact of gender: Rivaroxaban for patients with atrial fibrillation in the XANTUS real-world prospective study.
    Clin Cardiol. 2020 Sep 8. doi: 10.1002/clc.23452.
    PubMed     Abstract available

  80. ELZENEINI M, Assaf Y, Aalaei-Andabili SH, Mahmoud A, et al
    Predictors of ventricular pacing burden after permanent pacemaker implantation following transcatheter aortic valve replacement.
    Clin Cardiol. 2020 Sep 4. doi: 10.1002/clc.23447.
    PubMed     Abstract available

  81. GUPTA N, Patel K, Gupta R
    A word of caution.
    Clin Cardiol. 2020;43:927.

    Definition for AF course.
    Clin Cardiol. 2020;43:926.

    August 2020
  83. HUANG X, Chen Y, Huang Y, Zhao H, et al
    Comparative effects of intensive ganglionated plexus ablation in treating paroxysmal atrial fibrillation and vasovagal syncope.
    Clin Cardiol. 2020 Aug 17. doi: 10.1002/clc.23446.
    PubMed     Abstract available

  84. SCHUKRO C, Santer D, Prenner G, Stuhlinger M, et al
    State-of-the-art consensus on non-transvenous implantable cardioverter-defibrillator therapy.
    Clin Cardiol. 2020 Aug 14. doi: 10.1002/clc.23432.
    PubMed     Abstract available

    July 2020
  85. YAO Y, Liu F, Wang Y, Liu Z, et al
    Lipid levels and risk of new-onset atrial fibrillation: A systematic review and dose-response meta-analysis.
    Clin Cardiol. 2020 Jul 28. doi: 10.1002/clc.23430.
    PubMed     Abstract available

  86. KERWIN M, Saado J, Pan J, Ailawadi G, et al
    New-onset atrial fibrillation and outcomes following isolated coronary artery bypass surgery: A systematic review and meta-analysis.
    Clin Cardiol. 2020 Jul 21. doi: 10.1002/clc.23414.
    PubMed     Abstract available

  87. WANG XH, Kong LC, Li Z, Nie P, et al
    Mitral isthmus block is associated with favorable outcomes after reablation for long-standing persistent atrial fibrillation.
    Clin Cardiol. 2020 Jul 8. doi: 10.1002/clc.23415.
    PubMed     Abstract available

    June 2020
  88. JAVED S, Gupta D, Lip GYH
    Atrial fibrillation in obesity: Weighing up the evidence for catheter ablation.
    Clin Cardiol. 2020 Jun 29. doi: 10.1002/clc.23416.

  89. DAI Q, Deng X, Zhou L, Zhang L, et al
    Real-world use of nonvitamin K antagonist oral anticoagulant in atrial fibrillation patients with liver disease: A meta-analysis.
    Clin Cardiol. 2020 Jun 17. doi: 10.1002/clc.23408.
    PubMed     Abstract available

  90. LIU M, Mei K, Liu X, Zhao Y, et al
    Impact of body mass index on procedural complications, procedure duration, and radiation dose in patients with atrial fibrillation undergoing radiofrequency ablation: A systematic review and meta-analysis.
    Clin Cardiol. 2020 Jun 3. doi: 10.1002/clc.23398.
    PubMed     Abstract available

    May 2020
  91. SEEWOSTER T, Buttner P, Zeynalova S, Hindricks G, et al
    Are the atrial natriuretic peptides a missing link predicting low-voltage areas in atrial fibrillation? Introducing the novel biomarker-based atrial fibrillation substrate prediction (ANP) score.
    Clin Cardiol. 2020 May 27. doi: 10.1002/clc.23378.
    PubMed     Abstract available

  92. HE J, Fu Z, Yang L, Liu W, et al
    The predictive value of a concise classification of left atrial appendage morphology to thrombosis in non-valvular atrial fibrillation patients.
    Clin Cardiol. 2020 May 14. doi: 10.1002/clc.23381.
    PubMed     Abstract available

  93. SCIRIA CT, Maddox TM, Marzec L, Rodwin B, et al
    Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry.
    Clin Cardiol. 2020 May 6. doi: 10.1002/clc.23376.
    PubMed     Abstract available

  94. GOTZMANN M, Choudhury DS, Hogeweg M, Heringhaus F, et al
    Risk stratification in patients undergoing interventional left atrial appendage occlusion-Prognostic impact of EuroSCORE II.
    Clin Cardiol. 2020;43:508-515.
    PubMed     Abstract available

  95. CHEN CF, Zhong YG, Jin CL, Gao XF, et al
    Comparing between second-generation cryoballoon vs open-irrigated radiofrequency ablation in elderly patients: Acute and long-term outcomes.
    Clin Cardiol. 2020;43:500-507.
    PubMed     Abstract available

    April 2020
  96. LYU SQ, Yang YM, Zhu J, Wang J, et al
    Gender-specific association between body mass index and all-cause mortality in patients with atrial fibrillation.
    Clin Cardiol. 2020 Apr 30. doi: 10.1002/clc.23371.
    PubMed     Abstract available

  97. STARREVELD R, Knops P, Ramos KS, Roos-Serote MC, et al
    Atrial fibrillation fingerprinting; spotting bio-electrical markers to early recognize atrial fibrillation by the use of a bottom-up approach (AFFIP): Rationale and design.
    Clin Cardiol. 2020 Apr 18. doi: 10.1002/clc.23370.
    PubMed     Abstract available

  98. ZHANG H, Dong P, Yang X, Du L, et al
    Prognostic indicators of new onset atrial fibrillation in patients with acute coronary syndrome.
    Clin Cardiol. 2020 Apr 14. doi: 10.1002/clc.23363.
    PubMed     Abstract available

  99. POPOVIC D, Arena R, Jakovljevic D, Ristic A, et al
    Ventricular arrhythmias not meeting criteria for terminating cardiopulmonary exercise testing stratify prognosis and disease severity in heart failure of preserved, midrange, and reduced ejection fraction.
    Clin Cardiol. 2020 Apr 9. doi: 10.1002/clc.23367.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.